• 1
    Ornellas AA, Seixas ALC, Marota A, Wisnescky A, Campos F, De Moraes JR. Surgical treatment of invasive squamous cell carcinoma of the penis: Retrospective analysis of 350 cases. J Urol 1994; 151: 12449
  • 2
    Ravi T. Correlation between the extent of nodal involvement and survival following groin dissection for carcinoma of the penis. Br J Urol 1993; 72: 8179
  • 3
    Horenblas S. Lymphadenectomy for squamous cell carcinoma of the penis. Part 1: Diagnosis of lymph node metastasis. BJU Int 2001; 88: 46772
  • 4
    Horenblas S, Van Tinteren H. Squamous cell carcinoma of the penis, IV. Prognostic factors of survival: Analysis of tumor, nodes and metastasis classification system. J Urol 1994; 151: 123943
  • 5
    Lopes A, Hidalgo GS, Kowallski LP, Torloni H, Rossi BM, Fonseca FP. Prognostic factors in carcinoma of the penis: Multivariate analysis of 145 patients treated with amputation and lymphadenectomy. J Urol 1996; 156: 163742
  • 6
    Solsona E, Iborra I, Ribio J, Ricos JV, Calabuig C. Prospective validation of the association of local tumor stage and grade as a predictive factor for occult lymph node micrometastasis in patients with penile carcinoma and clinically negative inguinal lymph nodes. J Urol 2001; 165: 15069
  • 7
    Morgenstern NJ, Slaton JW, Levy DA, Ayala AG, Santos MW, Pettaway CA. Vascular invasion and tumor stage are independent prognosticators of lymph node metastasis in squamous penile cancer. J Urol 1999; 161: 158, A608
  • 8
    Emerson RE, Ulbright TN, Eble JN, Geary WA, Eckert GJ, Cheng L. Predicting cancer progression in patients with penile squamous cell carcinoma. the importance of depth of invasion and vascular invasion. Mod Pathol 2001; 14: 9638
  • 9
    Fraley EE, Zhang G, Manivel C, Niehans GA. The role of ilioinguinal lymphadenectomy and significance of histological differentiation in treatment of carcinoma of the penis. J Urol 1989; 142: 147882
  • 10
    Bevan-Thomas R, Slaton JW, Pettaway CA. Contemporary morbidity from lymphadenectomy for penile squamous cell carcinoma: The M.D. Anderson Cancer Center experience. J Urol 2002; 167: 163842
  • 11
    Scholzen T, Gerdes J. The Ki-67 protein. from the known and the unknown. J Cell Pathol 2000; 182: 31122
  • 12
    Liu M, Lawson G, Delos M et al. Predictive value of the fraction of cancer cells immunolabeled for proliferating cell nuclear antigen or Ki67 in biopsies of head and neck carcinomas to identify lymph node metastasis: Comparison with clinical and radiologic examinations. Head Neck 2003; 25: 2808
  • 13
    Welkoborsky HJ, Hinni M, Dienes HP, Mann WJ. Predicting recurrence and survival in patients with laryngeal cancer by means of DNA cytometry, tumor front grading, and proliferation markers. Ann Otol Rhinol Laryngol 1995; 104: 50310
  • 14
    Pignataro L, Capaccio P, Pruneri G et al. The predictive value of p53, MDM-2, cyclin D1 and Ki67 in the progression from low-grade dysplasia towards carcinoma of the larynx. J Laryngol Otol 1998; 112: 4559
  • 15
    Martins ACP, Faria SM, Cologna AJ, Suaid HJ, Tucci S. Immunoexpression of p53 protein and proliferating cell nuclear antigen in penile carcinoma. J Urol 2002; 167: 8993
  • 16
    Lopes A, Bezerra ALR, Lopes Pinto CA, Serrano SV, Abdon de Mello C, Villa LL. p53 as a new prognostic factor for lymph node metastasis in penile carcinoma. analysis of 82 patients treated with amputation and bilateral lymphadenectomy. J Urol 2002; 168: 816